| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.7M | +8.3% |
| Cost of Revenue | $6.7M | -6.0% |
| R&D Expense | $5.7M | -5.2% |
| SG&A Expense | $23.9M | +18.4% |
| Operating Income | -$49.6M | -7.8% |
| Pre-tax Income | -$58.0M | -27.4% |
| Income Tax | $0 | — |
| Net Income | -$58.0M | -27.4% |
| EPS (Basic) | -$0.69 | +34.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $643K | +1328.9% |
| Inventory | $353K | +3.5% |
| Current Assets | $37.5M | +49.0% |
| Total Assets | $40.4M | +31.7% |
| Current Liabilities | $28.6M | +21.5% |
| Total Liabilities | $29.5M | +16.5% |
| Stockholders' Equity | $10.9M | +102.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.5M | -5.3% |
| Capital Expenditures | $197K | -33.4% |
| Investing Cash Flow | -$197K | +69.5% |
| Financing Cash Flow | $59.0M | +22.3% |
| Free Cash Flow | -$46.7M | -5.1% |